ADAM-1: An AI Reasoning and Bioinformatics Model for Alzheimer’s Disease Detection and Microbiome-Clinical Data Integration
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Alzheimer's Disease Analysis Model Generation 1 (ADAM-1) is a multi-agent reasoning large language model (LLM) framework designed to integrate and analyze multimodal data, including microbiome profiles, clinical datasets, and external knowledge bases, to enhance the understanding and classification of Alzheimer's disease (AD). By leveraging the agentic system with LLM, ADAM-1 produces insights from diverse data sources and contextualizes the findings with literature-driven evidence. A comparative evaluation with XGBoost revealed a significantly improved mean F1 score and significantly reduced variance for ADAM-1, highlighting its robustness and consistency, particularly when utilizing human biological data. Although currently tailored for binary classification tasks with two data modalities, future iterations will aim to incorporate additional data types, such as neuroimaging and peripheral biomarkers, and expand them to predict disease progression, thereby broadening ADAM-1's scalability and applicability in AD research and diagnostic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1. The Nursing Home Cohort Clinical Data Description (source: [28]). (A) Bar plots illustrate the distribution of participants based on Alzheimer’s status and the prevalence of key comorbidities. 67.16% of participants do not have Alzheimer’s disease, while 32.84% do. The most prevalent comorbidities include hypertension (HTN), and various cardiovascular diseases (CVD), with prevalence categorized by Alzheimer’s status. (B) The demographic characteristics of the cohort (N=335) encompass age distribution, with a mean age of 84.5 years and a median age of 86.0 years, alongside a pie chart depicting gender distribution, which shows a predominance of females (85.7%) in the cohort. (C) Study participation metrics include the distribution of stool samples per participant and a longitudinal sampling timeline for the top 10 participants based on the number of samples collected. The median number of samples per participant is 3. Alzheimer’s status is color-coded across all visualizations.](https://figures.cochat.ai/paper-figures/01dbd91196044ed39caf7464590fdcef/adam-1-an-ai-reasoning-and-bioinformatics-model-for-alzheimers-disease-detection-figure-1.jpg)
![FIGURE 2. Nursing Home Cohort Bacteria Data Description (source: [28]). (A) Prevalence vs. Abundance of Bacterial Species: Scatter plot illustrating bacterial species by their prevalence (the number of samples in which each species appears) and proportional abundance across the dataset. Red dashed lines represent the filtering criteria applied during preprocessing: species present in fewer than 5% of samples (prevalence cutoff: 17) or with a total relative abundance below 1e-4 were removed to minimize noise and focus on biologically relevant taxa. (B) Volcano Plot of Differential Abundance: log2 fold change versus –log10 (p-value) for all bacterial species. Species with significantly higher abundance in Alzheimer’s patients are shown in red; those lower in AD are shown in blue.](https://figures.cochat.ai/paper-figures/fdcf2eb0d03742e4a1328139976ff84e/adam-1-an-ai-reasoning-and-bioinformatics-model-for-alzheimers-disease-detection-figure-2.jpg)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this distribution, post hoc explainability was not used as a standalone strategy but appeared exclusively in hybrid systems that combined intrinsic agent reasoning with attribution-based methods [20,22].”
From Explainable Agentic Artificial Intelligence in Healthcare: A Scoping Review (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-agent systems were predominantly role-based, with agents assigned to cognitively separable subtasks such as drafting, verification, retrieval, synthesis, supervision, or reporting [22,26,27].”
From Explainable Agentic Artificial Intelligence in Healthcare: A Scoping Review (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nine studies met the inclusion criteria.”
From Explainable Agentic Artificial Intelligence in Healthcare: A Scoping Review (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, others incorporated retrospective validation using benchmark or real-world datasets (e.g., ADAM-1, DrugAgent, EMAI, and CASSIA) [19,22,23,26].”
From Explainable Agentic Artificial Intelligence in Healthcare: A Scoping Review (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Only two systems supported both local and global explanation layers: ADAM-1 combined instance-level rationales with population-level feature-attribution summaries [22], and EMAI produced case-level explanations alongside generalized “experience” rules induced from historical report clusters [23].”
From Explainable Agentic Artificial Intelligence in Healthcare: A Scoping Review (2026) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
XGBoost: A Scalable Tree Boosting System
Chen, T., & Guestrin, C. (2016) · Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining · doi:10.1145/2939672.2939785 · Cited by 54,569
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
DeepSeek-R1: Incentivizing Reasoning Capability in LLMs via Reinforcement Learning
DeepSeek-AI, Guo, D., Yang, D., Zhang, H., Song, J., Wang, P., Zhu, Q., Xu, R., Zhang, R., Ma, S., et al. (2025) · arXiv · doi:10.48550/arxiv.2501.12948 · Cited by 18,918
Self-citationLarian Studios Dev Team (2024) · doi:10.1145/3292500.3330701 · Cited by 8,618 · cited 1×
“The model selection process involved two phases: feature selection and model training, both optimized using Optuna, which is a Bayesian-based hyperparameter-tuning framework [39].”
Evolutionary-scale prediction of atomic level protein structure with a language model
Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., Shmueli, Y., et al. (2022) · doi:10.1101/2022.07.20.500902 · Cited by 5,990
LLaMA: Open and Efficient Foundation Language Models
Touvron, H., Lavril, T., Izacard, G., Martinet, X., Lachaux, M.-A., Lacroix, T., Rozière, B., Goyal, N., Hambro, E., Azhar, F., et al. (2023) · arXiv · doi:10.48550/arxiv.2302.13971 · Cited by 4,602
Training language models to follow instructions with human feedback
Ouyang, L., Wu, J., Jiang, X., Almeida, D., Wainwright, C. L., Mishkin, P., Zhang, C., Agarwal, S., Slama, K., Ray, A., et al. (2022) · arXiv · doi:10.48550/arxiv.2203.02155 · Cited by 4,208
Nachar, N. (2008) · Tutorials in Quantitative Methods for Psychology · doi:10.20982/tqmp.04.1.p013 · Cited by 1,166
Gemini: A Family of Highly Capable Multimodal Models
Gemini Team, Anil, R., Borgeaud, S., Alayrac, J.-B., Yu, J., Soricut, R., Schalkwyk, J., Dai, A. M., Hauth, A., Millican, K., et al. (2023) · arXiv · doi:10.48550/arxiv.2312.11805 · Cited by 990
Research works printed but not linked: 13
- Radford, 2018, Improving Language Understanding by Generative Pre-Training
- Radford, 2025, Language models are unsupervised multitask learners, OpenAI, 1, 9
- 2024, The Claude 3 Model Family: Opus, Sonnet, Haiku
- 2025, OpenAI GPT-4.5 System Card
- 2025, OpenAI O1 System Card
- Kavukcuoglu, 2025, Gemini 2.5: Our Most Intelligent AI Model
- 2025, Claude 3.7 Sonnet and Claude Code
- Jin, 2024, Demystifying large language models for medicine: A primer, arXiv:2410.18856 · arXiv
- 10.1126/science.ade2574 · doi:10.1126/science.ade2574 · Paper page
- 2024, GPT-4o-Mini: Advancing Cost-Efficient Intelligence
- 2024, OpenAI Platform Documentation: Embeddings
- 2025, Pricing
- Iversen, 1987, Analysis of variance, 487
Cited by
Gut microbiome and metabolic health: mechanisms and precision interventions
Li, Z., Samui, S., Liu, J. S., Yang, Y., Liu, X., Chen, Q. W., Li, J. N., Gopinath, D., Luo, P., & Shan, D. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2644677 · Cited by 33
Artificial intelligence agents in healthcare research: A scoping review
Njei, B., Al-Ajlouni, Y. A., Sidney Kanmounye, U., Boateng, S., Loic Nguefang, G., Njei, N., Hamouri, S., & Al-Ajlouni, A. F. (2026) · PLOS One · doi:10.1371/journal.pone.0342182 · Cited by 27
“Although multi-agent systems aim to reduce hallucination through RAG and self-correction, LLM inconsistency and imperfect reliability persist, necessitating mandatory human oversight for patient safety [41].”
InfluentialYounesi, A., Oustad, E., Ansari, M., Fahringer, T., & Buyya, R. (2025) · Internet of Things · doi:10.1016/j.iot.2025.101815 · Cited by 34
Systematic Review: Agentic AI in Neuroradiology: Technical Promise with Limited Clinical Evidence
Salehi, S., Keishing, V., Singh, Y., Wei, D., Khosravi, A., Habibi, P., Jagtap, J. M. M., & Erickson, B. J. (2026) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-025-01839-2 · Cited by 5
Explainable Agentic Artificial Intelligence in Healthcare: A Scoping Review
Collaco, B. G., Prabha, S., Gomez-Cabello, C. A., Haider, S. A., Genovese, A., Wood, N. G., Gopala, N., Raman, R., Hester, E. O., & Forte, A. J. (2026) · Bioengineering · doi:10.3390/bioengineering13050513 · Cited by 3
“For example, CBM-RAG separated disease-specific reasoning from report synthesis [20]; ADAM-1 distinguished computational analysis from narrative interpretation [22]; and CASSIA partitioned annotation, validation, quality scoring, and reporting into discrete stages [26].”
Influential
Metadata
- Authors
- Huang, Z., Kaur Sekhon, V., Sadeghian, R., Vaida, M. L., Jo, C., McCormick, B. A., Ward, D. V., Bucci, V., & Haran, J. P.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Department of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, MD, USA
- Harrisburg University of Science and Technology (US)
- ORCID
- Venue
- IEEE Access
- Published
- 2025
- Volume
- 13
- Pages
- 145953-145967
- ISSN
- 2169-3536 (ISSN-L)
- PMC
- PMC12483529
- OpenAlex
- W4413277664
- Cited by
- 10
- References
- 25
- Citations by year
- 2026: 10
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- IEEE Access (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by)
- arXiv (Cornell University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- arXiv (Cornell University)
- Funders
- National Institutes of Health (R01AG067483-01)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, multi-agent large language models, agentic systems, multimodal data integration, microbiome data, clinical data, disease classification, XGBoost comparison, disease progression prediction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ADAM-1: An AI Reasoning and Bioinformatics Model for Alzheimer’s Disease Detection and Microbiome-Clinical Data Integration. https://app.cochat.ai/papers/10.1109/access.2025.3599857
- The paper
- Huang, Z., Kaur Sekhon, V., Sadeghian, R., Vaida, M. L., Jo, C., McCormick, B. A., Ward, D. V., Bucci, V., & Haran, J. P. (2025). ADAM-1: An AI Reasoning and Bioinformatics Model for Alzheimer’s Disease Detection and Microbiome-Clinical Data Integration. IEEE Access. https://doi.org/10.1109/access.2025.3599857
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.